Several studies have shown that VEGF expression in the malignant tissue and/or plasma correlates with aggressive disease (reviewed in Delongchamps et al, 2006) and VEGF mRNA and protein are upregulated in prostate carcinoma (Ferrer et al, 1997; Jackson et al, 1997). This evidence concerns the gene VEGFA and prostate carcinoma.